A major discovery in cancer investigation is emerging with the use of mini-antibodies to re-engage damaged p53. This vital malignant inhibitor protein is frequently lost in various forms of cancer, causing uncontrolled https://bookmarkjourney.com/story21948170/mini-antibodies-reactivate-tumor-suppressor-p53-a-promising-pathway-for-tumor-management